Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Here's Why Idera Pharmaceuticals Jumped as Much as 11.5% Today


Here's Why Idera Pharmaceuticals Jumped as Much as 11.5% Today

Shares of clinical-stage biopharma Idera Pharmaceuticals (NASDAQ: IDRA) jumped over 11% today without any company-specific news. Why? The two leading RNA-based genetic medicine companies were making waves and grabbing headlines -- and this tiny biopharma just so happens to be developing a similar therapeutic approach.

To recap, Alnylam Pharmaceuticals reported more details on the phase 3 trial of its lead drug candidate, which appears to be vastly more effective than a drug candidate from Ionis Pharmaceuticals in the same indication.

As of 3:26 p.m. EDT, the stock had settled to a 6.7% gain.

Continue reading


Source: Fool.com

Aceragen Inc. Aktie

0,45 €
-39,43 %
Die Aceragen Inc. Aktie notiert heute deutlich tiefer, mit einem Rückgang von -39,43 %.

Like: 0
Teilen

Kommentare